Healthcare -
Biotechnology - NYSE - US
$ 9.7
-2.02 %
$ 1.03 B
Market Cap
-3.09
P/E
RCUS - TOTAL RECEIVABLES
Total Receivables RCUS - Arcus Biosciences, Inc.
42 M
LAST VALUE
-76.26%
2 YEAR CAGR
247.40%
5 YEAR CAGR
0.00%
10 YEAR CAGR